E. Rakha, M. Sayed, A. Green, A. Lee, J. Robertson et al., Prognostic markers in triple-negative breast cancer, Cancer, vol.91, issue.1, pp.25-32, 2007.
DOI : 10.1002/cncr.22381
R. Dent, M. Trudeau, K. Pritchard, W. Hanna, H. Kahn et al., Triple-Negative Breast Cancer: Clinical Features and Patterns of Recurrence, Clinical Cancer Research, vol.13, issue.15, pp.4429-4463, 2007.
DOI : 10.1158/1078-0432.CCR-06-3045
B. Haffty, Q. Yang, M. Reiss, T. Kearney, S. Higgins et al., Locoregional Relapse and Distant Metastasis in Conservatively Managed Triple Negative Early-Stage Breast Cancer, Journal of Clinical Oncology, vol.24, issue.36, pp.5652-5659, 2006.
DOI : 10.1200/JCO.2006.06.5664
R. Millikan, B. Newman, C. Tse, P. Moorman, K. Conway et al., Epidemiology of basal-like breast cancer, Breast Cancer Research and Treatment, vol.315, issue.1 Suppl, pp.123-162, 2008.
DOI : 10.1007/s10549-007-9632-6
R. Schmadeka, B. Harmon, and M. Singh, Triple-Negative Breast Carcinoma: Current and Emerging Concepts, American Journal of Clinical Pathology, vol.141, issue.4, pp.462-77, 2014.
DOI : 10.1309/AJCPQN8GZ8SILKGN
N. Bushati and S. Cohen, microRNA Functions, Annual Review of Cell and Developmental Biology, vol.23, issue.1, pp.175-205, 2007.
DOI : 10.1146/annurev.cellbio.23.090506.123406
J. Bouyssou, S. Manier, D. Huynh, S. Issa, A. Roccaro et al., Regulation of microRNAs in cancer metastasis, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1845, issue.2, pp.255-65, 1845.
DOI : 10.1016/j.bbcan.2014.02.002
L. Ma, F. Reinhardt, E. Pan, J. Soutschek, B. Bhat et al., Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model, Nature Biotechnology, vol.52, issue.4, pp.341-348, 2010.
DOI : 10.4161/cc.8.22.9893
S. Kim, J. Shin, K. Lee, Y. Bae, K. Sung et al., MicroRNA let-7a suppresses breast cancer cell migration and invasion through downregulation of C-C chemokine receptor type 7, Breast Cancer Research, vol.294, issue.1, p.14, 2012.
DOI : 10.1126/science.1065329
S. Johnson, H. Grosshans, J. Shingara, M. Byrom, R. Jarvis et al., RAS Is Regulated by the let-7 MicroRNA Family, Cell, vol.120, issue.5, pp.635-682, 2005.
DOI : 10.1016/j.cell.2005.01.014
C. Blenkiron, L. Goldstein, N. Thorne, I. Spiteri, S. Chin et al., MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype, Genome Biology, vol.8, issue.10, p.214, 2007.
DOI : 10.1186/gb-2007-8-10-r214
M. Tanic, K. Yanowski, G. Gómez-lópez, R. Socorro, M. Marquez-rodas et al., MicroRNA expression signatures for the prediction of BRCA1/2 mutation-associated hereditary breast cancer in paraffin-embedded formalin-fixed breast tumors, International Journal of Cancer, vol.12, pp.593-602, 2015.
DOI : 10.1002/ijc.29021
D. Madhavan, M. Zucknick, M. Wallwiener, K. Cuk, C. Modugno et al., Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer, Clinical Cancer Research, vol.18, issue.21, pp.5972-82, 2012.
C. Roth, B. Rack, V. Muller, W. Janni, K. Pantel et al., Circulating microRNAs as blood-based markers for patients with primary and metastatic breast cancer, Breast Cancer Research, vol.219, issue.6, p.90, 2010.
DOI : 10.1002/path.2586
W. Zhu, W. Qin, U. Atasoy, and E. Sauter, Circulating microRNAs in breast cancer and healthy subjects, BMC Research Notes, vol.2, issue.1, p.89, 2009.
DOI : 10.1186/1756-0500-2-89
P. Mitchell, R. Parkin, E. Kroh, B. Fritz, S. Wyman et al., Circulating microRNAs as stable blood-based markers for cancer detection, Proceedings of the National Academy of Sciences, vol.105, issue.30, pp.2496-505, 2008.
DOI : 10.1073/pnas.0804549105
G. Koller, U. Schlomann, P. Golfi, T. Ferdous, S. Naus et al., ADAM8/MS2/CD156, an Emerging Drug Target in the Treatment of Inflammatory and Invasive Pathologies, Current Pharmaceutical Design, vol.15, issue.20, pp.2272-81, 2009.
DOI : 10.2174/138161209788682361
A. Fourie, F. Coles, V. Moreno, and L. Karlsson, Catalytic Activity of ADAM8, ADAM15, and MDC-L (ADAM28) on Synthetic Peptide Substrates and in Ectodomain Cleavage of CD23, Journal of Biological Chemistry, vol.278, issue.33, pp.30469-77, 2003.
DOI : 10.1074/jbc.M213157200
S. Naus, S. Reipschlager, D. Wildeboer, S. Lichtenthaler, S. Mitterreiter et al., Identification of candidate substrates for ectodomain shedding by the metalloprotease-disintegrin ADAM8, Biological Chemistry, vol.387, issue.3, pp.337-383, 2006.
DOI : 10.1515/BC.2006.045
J. Krätzschmar, L. Lum, and C. Blobel, Metargidin, a membrane-anchored metalloprotease-disintegrin protein with an RGD integrin binding sequence, J Biol Chem, vol.271, pp.4593-4599, 1996.
A. Stone, M. Kroeger, and Q. Sang, Structure-function analysis of the ADAM family of disintegrin-like and metalloproteinase-containing proteins (review)
U. Schlomann, D. Wildeboer, A. Webster, O. Antropova, D. Zeuschner et al., The Metalloprotease Disintegrin ADAM8: PROCESSING BY AUTOCATALYSIS IS REQUIRED FOR PROTEOLYTIC ACTIVITY AND CELL ADHESION, Journal of Biological Chemistry, vol.277, issue.50, pp.48210-48219, 2002.
G. Weskamp, J. Krätzschmar, M. Reid, and C. Blobel, MDC9, a widely expressed cellular disintegrin containing cytoplasmic SH3 ligand domains, The Journal of Cell Biology, vol.132, issue.4, pp.717-743, 1996.
DOI : 10.1083/jcb.132.4.717
M. Romagnoli, N. Mineva, M. Polmear, C. Conrad, S. Srinivasan et al., ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis, EMBO Molecular Medicine, vol.6, issue.Suppl. 6, pp.278-94, 2014.
DOI : 10.1002/emmm.201303373
F. Lerebours, G. Cizeron-clairac, A. Susini, S. Vacher, E. Mouret-fourme et al., miRNA expression profiling of inflammatory breast cancer identifies a 5-miRNA signature predictive of breast tumor aggressiveness, International Journal of Cancer, vol.6, issue.7, pp.1614-1637, 2013.
K. Ignatoski and S. Ethier, Constitutive activation of pp125fak in newly isolated human breast cancer cell lines, Breast Cancer Research and Treatment, vol.77, issue.2, pp.173-82, 1999.
DOI : 10.1023/A:1006135331912
M. Romagnoli, K. Belguise, Z. Yu, X. Wang, E. Landesman-bollag et al., Epithelial-to-Mesenchymal Transition Induced by TGF-??1 Is Mediated by Blimp-1-Dependent Repression of BMP-5, Cancer Research, vol.72, issue.23, pp.6268-78, 2012.
DOI : 10.1158/0008-5472.CAN-12-2270
S. Srinivasan, M. Romagnoli, A. Bohm, and G. Sonenshein, N-Glycosylation Regulates ADAM8 Processing and Activation, Journal of Biological Chemistry, vol.289, issue.48, pp.33676-88, 2014.
DOI : 10.1074/jbc.M114.594242
C. Théry, S. Amigorena, G. Raposo, and A. Clayton, Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids, Inc, vol.4, 2006.
DOI : 10.1002/0471143030.cb0322s30
M. Duffy, M. Mullooly, O. Donovan, N. Sukor, S. Crown et al., The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?, Clinical Proteomics, vol.8, issue.1, p.13, 2011.
DOI : 10.1038/nm0102-35
N. Mineva, X. Wang, S. Yang, H. Ying, Z. Xiao et al., promotes sensitivity of breast cancer cells to radiation, Journal of Cellular Physiology, vol.6, issue.3, pp.593-602, 2009.
DOI : 10.1002/jcp.21765
K. Belguise, S. Guo, and G. Sonenshein, Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor ?? Expression Reversing Invasive Phenotype of Breast Cancer Cells, Cancer Research, vol.67, issue.12, pp.5763-70, 2007.
R. Singh and Y. Mo, Role of microRNAs in breast cancer, Cancer Biology & Therapy, vol.287, issue.3, pp.201-213, 2013.
DOI : 10.1016/j.ajpath.2012.02.024
Z. Deng, J. Yin, Q. Tang, F. Liu, J. Qian et al., Over-expression of miR-98 in FFPE tissues might serve as a valuable source for biomarker discovery in breast cancer patients, Int J Clin Exp Pathol, vol.7, pp.1166-71, 2014.
A. Kolacinska, J. Morawiec, Z. Pawlowska, J. Szemraj, B. Szymanska et al., Association of microRNA-93, 190, 200b and Receptor Status in Core Biopsies from Stage III Breast Cancer Patients, DNA and Cell Biology, vol.33, issue.9, pp.624-633, 2014.
DOI : 10.1089/dna.2014.2419
E. Shinozuka, M. Miyashita, Y. Mizuguchi, I. Akagi, K. Kikuchi et al., SnoN/SKIL modulates proliferation through control of hsa-miR-720 transcription in esophageal cancer cells, Biochemical and Biophysical Research Communications, vol.430, issue.1, pp.101-107, 2013.
DOI : 10.1016/j.bbrc.2012.11.005
T. Yang, X. Yang, X. Chen, X. Wang, J. Hua et al., MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN, FEBS Letters, vol.138, issue.13, pp.2162-2171, 2014.
DOI : 10.1016/j.febslet.2014.04.050
Q. Huang, K. Gumireddy, M. Schrier, C. Le-sage, R. Nagel et al., The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis, Nature Cell Biology, vol.11, issue.2, pp.202-212, 2008.
N. Li, S. Kaur, J. Greshock, H. Lassus, X. Zhong et al., A Combined Array-Based Comparative Genomic Hybridization and Functional Library Screening Approach Identifies mir-30d As an Oncomir in Cancer, Cancer Research, vol.72, issue.1, pp.154-64, 2012.
C. Filho, C. Calvano-mendes, D. Carvalho, K. Maciel, G. Ricci et al., Triple-negative and luminal A breast tumors: differential expression of miR-18a-5p, miR-17-5p, and miR-20a-5p, Tumor Biology, vol.106, issue.37, pp.7733-7774, 2014.
Y. Wang, X. Zhang, H. Li, J. Yu, and X. Ren, The role of miRNA-29 family in cancer, European Journal of Cell Biology, vol.92, issue.3, pp.123-131, 2013.
DOI : 10.1016/j.ejcb.2012.11.004
M. Chan, C. Liaw, S. Ji, H. Tan, C. Wong et al., Identification of Circulating MicroRNA Signatures for Breast Cancer Detection, Clinical Cancer Research, vol.19, issue.16, pp.4477-87, 2013.
R. Søkilde, B. Kaczkowski, A. Podolska, S. Cirera, J. Gorodkin et al., Global microRNA Analysis of the NCI-60 Cancer Cell Panel, Molecular Cancer Therapeutics, vol.10, issue.3, pp.375-84, 2011.
DOI : 10.1158/1535-7163.MCT-10-0605
L. Pigati, S. Yaddanapudi, R. Iyengar, D. Kim, S. Hearn et al., Selective Release of MicroRNA Species from Normal and Malignant Mammary Epithelial Cells, PLoS ONE, vol.8, issue.10, p.13515, 2010.
DOI : 10.1371/journal.pone.0013515.s012
C. Jones, M. Zabolotskaya, A. King, H. Stewart, G. Horne et al., Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma, British Journal of Cancer, vol.37, issue.12, pp.1987-96, 2012.
B. Lehmann, J. Bauer, X. Chen, M. Sanders, A. Chakravarthy et al., Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies, Journal of Clinical Investigation, vol.121, issue.7, pp.2750-67, 2011.
DOI : 10.1172/JCI45014DS1
T. Wolfsberg, P. Primakoff, D. Myles, and J. White, ADAM, a novel family of membrane proteins containing A Disintegrin And Metalloprotease domain: multipotential functions in cell-cell and cell- matrix interactions, The Journal of Cell Biology, vol.131, issue.2, pp.275-283, 1995.
K. Eto, C. Huet, T. Tarui, S. Kupriyanov, H. Liu et al., Functional Classification of ADAMs Based on a Conserved Motif for Binding to Integrin ??9??1: IMPLICATIONS FOR SPERM-EGG BINDING AND OTHER CELL INTERACTIONS, Journal of Biological Chemistry, vol.277, issue.20, pp.17804-17814, 2002.
M. Berry, A. Goode, J. Puddefoot, G. Vinson, and R. Carpenter, Integrin??1-mediated invasion of human breast cancer cells: anex vivo assay for invasiveness, Breast Cancer, vol.55, issue.3, pp.214-223, 2003.
DOI : 10.1007/BF02966720
H. Lahlou and W. Muller, ??1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer, Breast Cancer Research, vol.94, issue.18 Pt 1, p.229, 2001.
DOI : 10.1186/bcr2905
H. Ishizuka, V. García-palacios, G. Lu, M. Subler, H. Zhang et al., ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo, Journal of Bone and Mineral Research, vol.355, issue.1, pp.169-81, 2011.
DOI : 10.1002/jbmr.199
W. Guo and F. Giancotti, Integrin signalling during tumour progression, Nature Reviews Molecular Cell Biology, vol.14, issue.10, pp.816-842, 2004.
DOI : 10.1101/GAD.903001
D. White and W. Muller, Multifaceted Roles of Integrins in Breast Cancer Metastasis, Journal of Mammary Gland Biology and Neoplasia, vol.2, issue.3, pp.135-177, 2007.
M. Ohori, T. Kinoshita, M. Okubo, K. Sato, A. Yamazaki et al., Identification of a selective ERK inhibitor and structural determination of the inhibitor???ERK2 complex, Biochemical and Biophysical Research Communications, vol.336, issue.1, pp.357-63, 2005.
D. Price and J. Murray, Beta-1 Integrins mediate tumour cell adhesion to quiescent endothelial cells in vitro, British Journal of Cancer, vol.74, issue.11, pp.1762-1768, 1996.
DOI : 10.1038/bjc.1996.627
W. Zhu, W. Qin, U. Atasoy, and E. Sauter, Circulating microRNAs in breast cancer and healthy subjects, BMC Research Notes, vol.2, issue.1, pp.1-5, 2009.
M. Iorio, M. Ferracin, C. Liu, A. Veronese, R. Spizzo et al., MicroRNA Gene Expression Deregulation in Human Breast Cancer, Cancer Research, vol.65, issue.16, pp.7065-70, 2005.
D. Serpico, L. Molino, D. Cosimo, and S. , microRNAs in breast cancer development and treatment, Cancer Treatment Reviews, vol.40, issue.5, pp.595-604, 2013.
DOI : 10.1016/j.ctrv.2013.11.002
H. Butz, K. Rácz, L. Hunyady, and A. Patócsemail, Crosstalk between TGF-?? signaling and the microRNA machinery, Trends in Pharmacological Sciences, vol.33, issue.7, pp.382-93, 2012.
DOI : 10.1016/j.tips.2012.04.003
X. Wang, X. Zhao, P. Gao, and M. Wu, c-Myc modulates microRNA processing via the transcriptional regulation of Drosha, Scientific Reports, vol.64, 1942.
DOI : 10.1038/srep01942
M. Ragusa, L. Statello, M. Maugeri, A. Majorana, D. Barbagallo et al., Specific alterations of the microRNA transcriptome and global network structure in colorectal cancer after treatment with MAPK/ERK inhibitors, Journal of Molecular Medicine, vol.18, issue.12, pp.1421-1459, 2012.
E. Hara, M. Ono, T. Eguchi, S. Kubota, H. Pham et al., miRNA-720 Controls Stem Cell Phenotype, Proliferation and Differentiation of Human Dental Pulp Cells, PLoS ONE, vol.430, issue.12, p.83545, 2013.
X. Wang, Y. Kuang, X. Shen, H. Zhou, Y. Chen et al., Evaluation of miR-720 prognostic significance in patients with colorectal cancer, Tumor Biology, vol.31, issue.1, pp.719-746, 2015.
DOI : 10.1007/s13277-014-2697-z
I. Park, J. Kang, K. Lee, S. Nam, J. Ro et al., Identification and clinical implications of circulating microRNAs for estrogen receptor-positive breast cancer, Tumor Biology, vol.118, issue.10, pp.12173-80, 2014.
M. Sand, M. Skrygan, D. Sand, D. Georgas, T. Gambichler et al., Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi, Cell and Tissue Research, vol.8, issue.1, pp.85-98, 2013.
Y. Tang, Y. Lin, C. Li, X. Hu, Y. Liu et al., MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells, Cell & Bioscience, vol.77, issue.1, p.56, 2015.
R. Nonaka, Y. Miyake, T. Hata, Y. Kagawa, T. Kato et al., Circulating miR-103 and miR-720 as novel serum biomarkers for patients with colorectal cancer, International Journal of Oncology, vol.47, pp.1097-102, 2015.
DOI : 10.3892/ijo.2015.3064
D. Armstrong, B. Green, J. Seigne, A. Schned, and C. Marsit, MicroRNA molecular profiling from matched tumor and bio-fluids in bladder cancer, Molecular Cancer, vol.9, issue.6, p.194, 2015.
Z. Yi, Y. Fu, S. Zhao, X. Zhang, and C. Ma, Differential expression of miRNA patterns in renal cell carcinoma and nontumorous tissues, Journal of Cancer Research and Clinical Oncology, vol.27, issue.12, pp.855-62, 2010.
DOI : 10.1007/s00432-009-0726-x
L. Li, C. Zhang, L. Liu, C. Yi, S. Lu et al., miR-720 inhibits tumor invasion and migration in breast cancer by targeting TWIST1, Carcinogenesis, vol.35, issue.2, pp.469-78, 2014.
DOI : 10.1093/carcin/bgt330
M. Nieman, R. Prudoff, K. Johnson, and M. Wheelock, N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin Expression, The Journal of Cell Biology, vol.54, issue.3, pp.631-675, 1999.
DOI : 10.1172/JCI119387
U. Shankavaram, W. Reinhold, S. Nishizuka, S. Major, D. Morita et al., Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study, Molecular Cancer Therapeutics, vol.6, issue.3, pp.820-852, 2007.
M. Taylor, K. Sossey-alaoui, C. Thompson, D. Danielpour, and W. Schiemann, TGF-?? upregulates miR-181a expression to promote breast cancer metastasis, Journal of Clinical Investigation, vol.123, issue.1, pp.150-63, 2013.
X. Wang and Z. Chen, MicroRNA-19a functions as an oncogenic microRNA in non-small cell lung cancer by targeting the suppressor of cytokine signaling 1 and mediating STAT3 activation, Int J Mol Med, vol.35, pp.839-885, 2015.
B. Singh, A. Ronghe, A. Chatterjee, N. Bhat, and H. Bhat, MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis, Carcinogenesis, vol.34, issue.5, pp.1165-72, 2013.
L. Ma, Role of miR-10b in breast cancer metastasis, Breast Cancer Research, vol.454, issue.5, p.210, 2010.
Y. Shi, X. Luo, P. Li, J. Tan, X. Wang et al., miR-7-5p suppresses cell proliferation and induces apoptosis of breast cancer cells mainly by targeting REG??, Cancer Letters, vol.358, issue.1, pp.27-36, 2015.
DOI : 10.1016/j.canlet.2014.12.014
E. Jung, L. Santarpia, J. Kim, F. Esteva, E. Moretti et al., Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients, Cancer, vol.8, issue.10, pp.2603-2617, 2012.
V. Shin, J. Siu, I. Cheuk, E. Ng, and A. Kwong, Circulating cell-free miRNAs as biomarker for triple-negative breast cancer, British Journal of Cancer, vol.5, issue.11, pp.1751-1760, 2015.
DOI : 10.1038/cdd.2014.109
S. Mishra, A. Srivastava, S. Suman, V. Kumar, and Y. Shukla, Circulating miRNAs revealed as surrogate molecular signatures for the early detection of breast cancer, Cancer Letters, vol.369, issue.1, pp.67-75, 2015.
H. Si, X. Sun, Y. Chen, Y. Cao, S. Chen et al., Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer, Journal of Cancer Research and Clinical Oncology, vol.282, issue.2, pp.223-232, 2013.
DOI : 10.1007/s00432-012-1315-y
E. Ng, R. Li, V. Shin, H. Jin, C. Leung et al., Circulating microRNAs as Specific Biomarkers for Breast Cancer Detection, PLoS ONE, vol.54, issue.1, p.53141, 2013.
F. Mar-aguilar, R. Mendoza, I. Malagón-santiago, P. Espino-silva, S. Santuario-facio et al., Serum Circulating microRNA Profiling for Identification of Potential Breast Cancer Biomarkers, Disease Markers, vol.34, issue.3, pp.163-172, 2013.
DOI : 10.1155/2013/259454
K. Cuk, M. Zucknick, J. Heil, D. Madhavan, S. Schott et al., Circulating microRNAs in plasma as early detection markers for breast cancer, International Journal of Cancer, vol.14, issue.7, pp.1602-1614, 2013.
M. Schrauder, R. Strick, R. Schulz-wendtland, P. Strissel, L. Kahmann et al., Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection, PLoS ONE, vol.6, issue.1, 2012.
K. Sahlberg, K. Bottai, G. Naume, B. Burwinkel, B. Calin et al., A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients, Clinical Cancer Research, vol.21, issue.5, pp.1207-1221, 2015.
A. Godfrey, Z. Xu, C. Weinberg, R. Getts, P. Wade et al., Serum microRNA expression as an early marker for breast cancer risk in prospectively collected samples from the Sister Study cohort, Breast Cancer Research, vol.313, issue.3, p.42, 2013.
DOI : 10.1002/9780471420194